Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.120 | None | 0.667 | 1 | 2 | 2007 | 2014 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.200 | None | 0.800 | 2 | 1 | 2005 | 2018 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.620 | None | 0.800 | 1 | 1 | 2010 | 2016 | ||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
disease | 0.130 | None | 0.875 | 2 | 2 | 2010 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.880 | 1 | 4 | 1994 | 2019 | ||||||||
|
solute carrier family 22 member 4 | 0.603 | 0.769 | 1.8E-08 |
|
disease | 0.500 | None | 0.896 | 1 | 2 | 2003 | 2017 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 12 | 20 | 1998 | 2019 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 3 | 3 | 2007 | 2020 | |||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.950 | 13 | 19 | 2006 | 2020 | ||||||||
|
autophagy related 16 like 1 | 0.543 | 0.769 | 0.96 |
|
disease | 0.700 | None | 0.953 | 8 | 5 | 2001 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.500 | strong | 0.969 | 2 | 2 | 2008 | 2019 | ||||||||
|
TNF superfamily member 15 | 0.531 | 0.692 | 2.8E-03 |
|
disease | 0.200 | None | 0.979 | 4 | 9 | 2003 | 2019 | ||||||||
|
chromosome 1 open reading frame 141 | 0.691 | 0.385 | 3.2E-03 |
|
disease | 0.100 | None | 1.000 | 6 | 16 | 2006 | 2019 | ||||||||
|
IRF1 antisense RNA 1 | 0.670 | 0.385 | 4.2E-03 |
|
disease | 0.100 | None | 1.000 | 4 | 4 | 2007 | 2017 | ||||||||
|
bassoon presynaptic cytomatrix protein | 0.769 | 0.308 | 1.00 |
|
disease | 0.110 | None | 1.000 | 4 | 7 | 2007 | 2016 | ||||||||
|
pseudouridine synthase 10 | 0.736 | 0.346 | 7.9E-14 |
|
disease | 0.110 | None | 1.000 | 4 | 3 | 2008 | 2017 | ||||||||
|
protein tyrosine phosphatase non-receptor type 2 | 0.538 | 0.692 | 1.00 |
|
disease | 0.500 | None | 1.000 | 3 | 2 | 2007 | 2018 | ||||||||
|
laccase domain containing 1 | 0.700 | 0.423 | 1.2E-05 |
|
disease | 0.170 | None | 1.000 | 3 | 1 | 2008 | 2018 | ||||||||
|
strawberry notch homolog 2 | 0.663 | 0.538 | 7.1E-03 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2008 | 2017 | ||||||||
|
fucosyltransferase 2 | 0.552 | 0.731 | 5.3E-14 |
|
disease | 0.500 | None | 1.000 | 2 | 2 | 2010 | 2020 | ||||||||
|
T cell leukemia translocation altered | 0.861 | 0.231 | 4.6E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2007 | 2008 | ||||||||
|
caveolae associated protein 1 | 0.559 | 0.654 | 5.0E-03 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2008 | 2010 | ||||||||
|
small Cajal body-specific RNA 5 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2013 | |||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2008 | 2017 | ||||||||
|
interferon gamma receptor 2 | 0.597 | 0.577 | 0.95 |
|
disease | 0.120 | None | 1.000 | 2 | 2 | 2012 | 2018 |